ILMN

Illumina Inc

$268.53

0.00 (0.00%) Today

1.47 (0.54%) Pre-market

— up— down

Compare ILMN

Market Cap

$40.77B+194.5%

Revenue (TTM)

$4.44B+4.9%

Net Income (TTM)

$813.99M-31.9%

EPS (TTM)

5.38-31.9%

Shares Out

151.30M

P/E Ratio

49.42

Forward P/E

42.06

Open

$270.00

Previous Close

$270.00

Day Range

$267.66 – $276.97

52-Week Range

$88.00 – $277.95

Beta

1.48

Volume

5.03M

Avg Volume

2.40M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About ILMN

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

A vs